| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1691 | 2020 |
| Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract S Mehandru, MA Poles, K Tenner-Racz, A Horowitz, A Hurley, C Hogan, ... The Journal of experimental medicine 200 (6), 761-770, 2004 | 1499 | 2004 |
| Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry A Horowitz, DM Strauss-Albee, M Leipold, J Kubo, N Nemat-Gorgani, ... Science translational medicine 5 (208), 208ra145-208ra145, 2013 | 592 | 2013 |
| Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells D Wu, GW Xing, MA Poles, A Horowitz, Y Kinjo, B Sullivan, ... Proceedings of the National Academy of Sciences 102 (5), 1351-1356, 2005 | 298 | 2005 |
| Sinai Immunology Review Project. Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 266 | 2020 |
| Monalizumab: inhibiting the novel immune checkpoint NKG2A T Van Hall, P André, A Horowitz, DF Ruan, L Borst, R Zerbib, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 221 | 2019 |
| Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report M Markowitz, H Mohri, S Mehandru, A Shet, L Berry, R Kalyanaraman, ... The Lancet 365 (9464), 1031-1038, 2005 | 210 | 2005 |
| Class I HLA haplotypes form two schools that educate NK cells in different ways A Horowitz, Z Djaoud, N Nemat-Gorgani, J Blokhuis, HG Hilton, V Béziat, ... Science immunology 1 (3), eaag1672-eaag1672, 2016 | 185 | 2016 |
| NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination A Horowitz, RH Behrens, L Okell, AR Fooks, EM Riley The Journal of Immunology 185 (5), 2808-2818, 2010 | 173 | 2010 |
| Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes A Horowitz, KC Newman, JH Evans, DS Korbel, DM Davis, EM Riley The Journal of Immunology 184 (11), 6043-6052, 2010 | 161 | 2010 |
| Activation of natural killer cells during microbial infections A Horowitz, KA Stegmann, EM Riley Frontiers in immunology 2, 88, 2012 | 160 | 2012 |
| Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing SL Smith, PR Kennedy, KB Stacey, JD Worboys, A Yarwood, S Seo, ... Blood advances 4 (7), 1388-1406, 2020 | 150 | 2020 |
| Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells V Ramsuran, V Naranbhai, A Horowitz, Y Qi, MP Martin, Y Yuki, X Gao, ... Science 359 (6371), 86-90, 2018 | 150 | 2018 |
| Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy O Huhn, MA Ivarsson, L Gardner, M Hollinshead, JC Stinchcombe, ... Nature Communications 11 (1), 381, 2020 | 115 | 2020 |
| A distinct subset of human NK cells expressing HLA‐DR expand in response to IL‐2 and can aid immune responses to BCG JH Evans, A Horowitz, M Mehrabi, EL Wise, JE Pease, EM Riley, ... European journal of immunology 41 (7), 1924-1933, 2011 | 106 | 2011 |
| Fibroblast growth factor receptor 3 alterations and response to PD-1/PD-L1 blockade in patients with metastatic urothelial cancer L Wang, Y Gong, A Saci, PM Szabo, A Martini, A Necchi, A Siefker-Radtke, ... European urology 76 (5), 599-603, 2019 | 105 | 2019 |
| Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS, S/AS01 malaria vaccine A Horowitz, JCR Hafalla, E King, J Lusingu, D Dekker, A Leach, P Moris, ... The Journal of Immunology 188 (10), 5054-5062, 2012 | 89 | 2012 |
| Coordinated regulation of NK receptor expression in the maturing human immune system DM Strauss-Albee, A Horowitz, P Parham, CA Blish The Journal of Immunology 193 (10), 4871-4879, 2014 | 88 | 2014 |
| Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells Z Djaoud, LA Guethlein, A Horowitz, T Azzi, N Nemat-Gorgani, D Olive, ... Journal of Experimental Medicine 214 (6), 1827-1841, 2017 | 84 | 2017 |
| Synthesis and human NKT cell stimulating properties of 3-O-sulfo-α/β-galactosylceramides GW Xing, D Wu, MA Poles, A Horowitz, M Tsuji, DD Ho, CH Wong Bioorganic & medicinal chemistry 13 (8), 2907-2916, 2005 | 73 | 2005 |
Dara Strauss-AlbeePhD Student, Stanford UniversityVerified email at stanford.edu
